EON Network: September 2025 Newsletter |
The EON Network was established to facilitate communication between exercise oncology and oncology nutrition researchers and clinicians to achieve our joint goal of improving cancer treatment outcomes.
The EON Network monthly newsletter includes upcoming webinars, updates on exercise oncology and oncology nutrition related events, publications that may be of interest, and resources. This information is also available on the EON Network webpage. Past newsletters are archived.
|
|
|
EON Webinar Series: 2025-2026 Presenters
|
The EON Webinar Series returns this fall with an outstanding group of speakers!
As a reminder, recordings of past webinars are available on the EON Network webpage.
|
|
|
October 23, 2025 | 2:00 - 3:00 PM ET
|
|
|
| Exercise Oncology and Oncology Nutrition research funding opportunities with AICR and ACS
Join us as Nigel Brockton, PhD of the American Institute for Cancer Research (AICR) and Joanne Elena, PhD, MPH of the American Cancer Society (ACS) review the research funding opportunities offered by their organizations, as well as their organization's funding priorities. Dr. Brockton will also address the recent AICR announcement regarding harmonization of AICR and World Cancer Research Fund (WCRF) grants fundings program, and the focus on the INSPIRE Research Challenge mechanism during the transition.
|
|
|
December 4, 2025 | 3:00 - 4:00 PM ET
|
|
|
| The CHALLENGE Trial was Positive: What's Next for the Field of Exercise Oncology?
In this presentation, Prof. Courneya will present the results of the groundbreaking CHALLENGE trial demonstrating that structured exercise after adjuvant chemotherapy for colon cancer improves survival. He will then discuss the implications of the first positive phase 3 exercise trial on clinical practice and future research.
|
|
|
February 26, 2026 | 3:00 - 4:00 PM ET
|
|
|
| Improving Oncology Outcomes Through Targeted Nutritional Assessment and Intervention
Cancer and its treatments substantially impact nutritional status and overall patient outcomes. Malnutrition and muscle loss are highly prevalent challenges that compromise treatment tolerance, increase toxicity, and diminish quality of life and survival. This presentation will highlight emerging evidence on the role of targeted nutrition strategies, emphasizing the importance of comprehensive assessment and individualized intervention. Drawing on data from clinical trials and translational research, the session will explore updated insights into energy and protein requirements in oncology, including how factors such as inflammation influence anabolic response. It will also underscore the importance of integrating nutrition into multidisciplinary cancer care to optimize outcomes across the continuum.
|
|
|
April 9, 2026 | 2:00 - 3:00 PM ET
|
|
|
| Coffee consumption and improved colorectal cancer survivorship: from observational to interventional studies
Observational findings from several independent cohorts have consistently shown a beneficial association of coffee consumption after diagnosis with better survival outcomes among patients with colorectal cancer. In support of these data, coffee has been linked to lower risk of metabolic disorders, lower inflammation, and favorable blood biochemical profiles. While the components in coffee that drive these benefits remain unknown, studies of metabolomics and microbiome have identified potential molecules and mechanisms of action underlying coffee's beneficial effects. These data altogether have motivated the conduct of the first randomized control trial of coffee consumption among colorectal cancer survivors (the COMMENCER trial). In this presentation, Dr. Song will review the existing data, present the COMMENCER trial, and discuss the future directions.
|
|
|
|
A new publication in the Journal of the Academy of Nutrition and Dietetics by Rachel Hoobler, Mary C. Playdon, and colleagues describes the association between malnutrition and adverse chemotherapy experiences and outcomes among patients with diverse cancer diagnoses, not just those with head and neck and gastrointestinal cancers.
Read the full article here.
|
|
|
Hoobler R, Herrera M, Woodruff K, Sanchez A, Coletta AM, Chaix A, Elizondo J, Playdon MC. Malnutrition risk is associated with all-cause mortality and chemotherapy complications among adults diagnosed with diverse cancer types: a retrospective cohort study. J Acad Nutr Diet 2025 May 5:S2212-2672(25)00153-4. Epub ahead of print. PMID: 40334935
Morder KM, Nguyen M, Wilfahrt DN, Dahmani ZL, Burr AB, Xie B, Morikone M, Nieves-Rosado H, Gunn WG, Hurd DE, Wang H, Mullett SJ, Bossong K, Gelhaus SL, Rajasundaram D, Kane LP, Delgoffe GM, Das J, Davar D, Overacre-Delgoffe AE. Sucralose consumption ablates cancer immunotherapy response through microbiome disruption. Cancer Discov 2025 Jul 30. Epub ahead of print. PMID: 40742298
Schmitz KH, Wiskemann J, May AM. Exercise oncology comes of age. J Natl Cancer Inst Monogr 2025 Sep 1;2025(71):301-303. PMID: 40828157
Nicholson B, Moraitis AM, Cawley K, Wong B, Echeverria C, Mooney K. Step count and symptom severity during cancer treatment using the Symptom Care at Home digital platform. Support Care Cancer 2025 Aug 4;33(8):747. PMID: 40758176
Siebert S, Kersten J, Tomanek A, Heinz S, Niels T, Baumann FT. Lending a hand: supportive exercise therapy for cancer treatment-induced polyneuropathy of the upper extremity-VISCIPH A. Support Care Cancer 2025 Jul 22;33(8):712. PMID: 40694173
Luo Y, Ren Y, Li Y, Yang R, Cheng Y, Chen Y, Deng Y, Zheng J, Wang Y. Safety, feasibility, and effectiveness of exercise interventions in patients with hematologic malignancy during chemotherapy: a systematic review and meta-analysis. Support Care Cancer 2025 Jul 11;33(8):685. PMID: 40646359
Tuğral A, Arıbaş Z, Kaya Uçar G, Arslan FD, Bakar Y, Karakoyun I, Akyol M. The effect of supervised aerobic exercise on adipokine and myokine biomarkers in patients with cancer during systemic chemotherapy: a single-blinded prospective controlled trial. Support Care Cancer 2025 Aug 2;33(8):741. PMID: 40751845
Kastrati K, Huebner J, Kipp AP, Mathies V. Nutritional care in metastatic RCC: patient experiences and reported unaddressed needs. Support Care Cancer 2025 Aug 4;33(8):754. PMID: 40760061
Aichi M, Kozuka A, Suzuki Y, Shinoda S, Itai T, Kamiya N, Ishidera Y, Imai Y, Miyagi E, Mizushima T. Body composition as a predictive factor for chemotherapy-induced peripheral neuropathy and dose-limiting toxicity in patients with endometrial cancer undergoing carboplatin and paclitaxel. Int J Gynecol Cancer 2025 Aug 10;35(10):102108. Epub ahead of print. PMID: 40896849
Dunn R. Gastrointestinal symptoms during cancer therapy: the clinician's role. Adv Nutr 2025 Jul 11:100472. Epub ahead of print. PMID: 40653269
Alzoubi Z, Loman BR. Nutrition interventions in the treatment of gastrointestinal symptoms during cancer therapy: a systematic review and meta-analysis. Adv Nutr 2025 Jul 22:100485. Epub ahead of print. PMID: 40706958
|
|
|
| Call for Papers: Lifestyle Behavior and Cancer Care |
|
|
Drs. Hannah Wardill and Paolo Bossi are co-editing a special issue of the new journal Academia Oncology. Submissions are open on the topic of lifestyle behavior and cancer care, and are due by October 31, 2025. All types of articles (e.g. primary research, editorial, review, protocol) are accepted.
Both the prevention and treatment of cancer are profoundly influenced by lifestyle choices. Modifiable factors such as diet, physical activity, smoking, and alcohol consumption have consistently been linked to variations in cancer risk and prognosis, as demonstrated by extensive epidemiological research. Adopting lifestyle changes can significantly improve the quality of life and treatment outcomes for cancer patients. For instance, engaging in physical activity during and after cancer treatment has been shown to enhance overall physical function, alleviate depressive symptoms, and reduce fatigue. Additionally, maintaining a healthy weight and following a balanced diet can strengthen the immune system and decrease the risk of cancer recurrence. Psychological factors, such as stress management and social support, also play a vital role in promoting recovery and well-being. Incorporating lifestyle modifications into cancer care not only aids in prevention but also supports patients in managing their illness and enhancing their quality of life.
This special issue will focus on the critical role of lifestyle changes in cancer care, highlighting their impact on prevention, treatment outcomes, and overall patient well-being.
|
|
|
| Call for Papers: Supportive Care in Cancer Special Issue on Cancer-related Fatigue
|
|
|
Drs. Nicolas Hart and Amber Kleckner are leading a special issue of Supportive Care in Cancer on cancer-related fatigue.
This series on cancer-related fatigue focuses on the full spectrum of studies that may improve outcomes for people affected by cancer experiencing cancer-related fatigue. This may include prevention, screening, assessment, diagnosis, interventions, self-management support, and models of care to enhance clinical management, health service performance, and implementation science strategies.
Supportive Care in Cancer is published by Springer in a hybrid format, meaning that you can select "subscription-based," so authors do not have to pay a Article Processing Charges (APC), or "open access," in which the article will be freely available online to everyone.
|
|
|
Manage your preferences | Opt Out using TrueRemove™
Got this as a forward? Sign up to receive our future emails.
View this email online.
|
6110 Executive Blvd Suite 750 | Rockville, MD 20852 US
|
|
|
This email was sent to .
To continue receiving our emails, add us to your address book.
| |
|
|
